Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Tomoe Kazama"'
Autor:
Tsukasa Yamakawa, Takakazu Miyake, Yoshihiro Yokoyama, Tomoe Kazama, Yuki Hayashi, Daisuke Hirayama, Shinji Yoshii, Hiro‐o Yamano, Satoshi Takahashi, Hiroshi Nakase
Publikováno v:
JGH Open, Vol 8, Iss 6, Pp n/a-n/a (2024)
Abstract Background and Aim Recently, noninvasive fecal markers have been used as indicators of intestinal inflammation in patients with inflammatory bowel disease (IBD). We conducted a clinical validation study to measure fecal calprotectin (Cp), la
Externí odkaz:
https://doaj.org/article/12ab5522a55a4cdc924648d8272615c8
Autor:
Hiroki Kurumi, Yoshihiro Yokoyama, Takehiro Hirano, Kotaro Akita, Yuki Hayashi, Tomoe Kazama, Hajime Isomoto, Hiroshi Nakase
Publikováno v:
Biomedicines, Vol 12, Iss 5, p 952 (2024)
Cytokine-targeted therapies have shown efficacy in treating patients with ulcerative colitis (UC), but responses to these advanced therapies can vary. This variability may be due to differences in cytokine profiles among patients with UC. While the e
Externí odkaz:
https://doaj.org/article/a6c6ffddaf434dd59b517a67fb0686b9
Autor:
Tomoe Kazama, Katsuyoshi Ando, Nobuhiro Ueno, Mikihiro Fujiya, Takahiro Ito, Atsuo Maemoto, Keisuke Ishigami, Masanori Nojima, Hiroshi Nakase
Publikováno v:
PLoS ONE, Vol 18, Iss 9, p e0288393 (2023)
BackgroundInfliximab (IFX) effectively treats patients with inflammatory bowel disease (IBD). IFX-biosimilar (IFX-BS) has the same amino acid sequence as that of the IFX originator, and its increasing use is expected to reduce national healthcare cos
Externí odkaz:
https://doaj.org/article/e80aa668838043b6b13d6d99466aedfb
Autor:
Tadashi Ichimiya, Tomoe Kazama, Keisuke Ishigami, Yoshihiro Yokoyama, Yuki Hayashi, Satoshi Takahashi, Takao Itoi, Hiroshi Nakase
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0286415 (2023)
BackgroundInflammatory bowel disease (IBD) is a chronic intestinal disorder characterized by recurrent flare-ups and remission. Leucine-rich α2-glycoprotein (LRG) has been developed as a new serum biomarker of disease activity in patients with IBD.
Externí odkaz:
https://doaj.org/article/e1e8083f39ff4fc0b1c1560e521fbca2
Autor:
Tsukasa Yamakawa, Keisuke Ishigami, Ayumu Takizawa, Yumemi Takada, Sae Ohwada, Yoshihiro Yokoyama, Tomoe Kazama, Daisuke Hirayama, Shinji Yoshii, Hiro‐O Yamano, Rina Ohizumi, Naofumi Bunya, Taro Sugawara, Mitsuhiro Tsujiwaki, Shintaro Sugita, Satoshi Takahashi, Eichi Narimatsu, Hiroshi Nakase
Publikováno v:
DEN Open, Vol 2, Iss 1, Pp n/a-n/a (2022)
Abstract Patients with coronavirus disease 2019 (COVID‐19) primarily cause respiratory symptoms. However, gastrointestinal (GI) symptoms can also occur. The endoscopic characteristics of the GI tract in COVID‐19 patients remain unclear. We herein
Externí odkaz:
https://doaj.org/article/819329ebb02e4c60be561533520a3e90
Autor:
Tsukasa Yamakawa, Keisuke Ishigami, Sae Ohwada, Tomoe Kazama, Daisuke Hirayama, Shinji Yoshii, Hiro-o Yamano, Hiroshi Nakase
Publikováno v:
Clinical Journal of Gastroenterology. 16:187-192
A 77-year-old patient with ulcerative colitis (UC) was transferred to our department because of worsening bloody diarrhea and abdominal pain, which was consistent with a UC flare. Two days after admission, she complained of cough and high fever. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96fdd144ae90229e8659adc0d32d289d
https://doi.org/10.1007/s12328-022-01737-y
https://doi.org/10.1007/s12328-022-01737-y
Autor:
Sae Ohwada, Keisuke Ishigami, Yoshihiro Yokoyama, Tomoe Kazama, Yoshiharu Masaki, Mamoru Takahashi, Shinji Yoshii, Hiro-o Yamano, Hirofumi Chiba, Hiroshi Nakase
Publikováno v:
Clinical Journal of Gastroenterology. 16:73-80
Patients with various cancers benefit from immune checkpoint inhibitors. However, immune checkpoint inhibitor-induced adverse events have also been reported, such as colitis. Prednisolone is the first-line treatment for immune-related adverse events,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18209a91c8dd7797af2f5f5f15a25418
https://doi.org/10.1007/s12328-022-01731-4
https://doi.org/10.1007/s12328-022-01731-4
Autor:
Yoshihiro Yokoyama, Tsukasa Yamakawa, Takakazu Miyake, Tomoe Kazama, Yuki Hayashi, Daisuke Hirayama, Hiroshi Nakase
Inflammatory bowel disease (IBD) is a chronic disorder that involves a complex cytokine network. Despite an array of treatment options, no predictive biomarkers for response to IBD treatment have been established. We aimed to identify predictive biom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::780f0b33e11dd9450f9d0298cadeef0f
https://doi.org/10.21203/rs.3.rs-2841128/v1
https://doi.org/10.21203/rs.3.rs-2841128/v1
Autor:
Hiro-o Yamano, Tomoe Kazama, Shintaro Sugita, Hiroshi Nakase, Masaki Murata, Keisuke Ishigami, Toshiyuki Kubo, Yasuhiro Shibata
Publikováno v:
Clinical Journal of Gastroenterology. 14:1661-1666
An 86-year-old woman was admitted to our hospital with anemia. She had never experienced symptoms of serositis. Colonoscopy revealed colitis with erosions and a friable mucosa. First, she was diagnosed with unclassified inflammatory bowel disease (IB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3cdb070085d21b67c4458f7220c74e8
https://doi.org/10.1007/s12328-021-01497-1
https://doi.org/10.1007/s12328-021-01497-1
Autor:
Hiroshi Nakase, Yoshihiro Yokoyama, Tadashi Ichimiya, Kohei Wagatsuma, Tomoe Kazama, Daisuke Hirayama, Tsukasa Yamakawa
Publikováno v:
Clinical Journal of Gastroenterology
Familial Mediterranean fever (FMF) in gastrointestinal involvement has been considered rare, but resent reports suggest that FMF causes enterocolitis which is similar endoscopic findings to inflammatory bowel disease. The clinical characteristics and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2df0cf56fc8e1545cd71616cd6429919
http://europepmc.org/articles/PMC8298211
http://europepmc.org/articles/PMC8298211